Publications by authors named "Kuslima Shogen"

Claim this Profile
C
Crystal structure of Onconase at 1.1 Å resolution--insights into substrate binding and collective motion.
Daniel E Holloway, Umesh P Singh, Kuslima Shogen, K Ravi Acharya

FEBS J· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onconase responsive genes in human mesothelioma cells: implications for an RNA damaging therapeutic agent.
Deborah A Altomare, Susanna M Rybak, Jianming Pei, Jacob V Maizel, Mitchell Cheung, Kuslima Shogen

BMC Cancer· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local controlled delivery of anti-neoplastic RNAse to the brain.
Joram Slager, Betty Tyler, Ariella Shikanov, Abraham J Domb, Kuslima Shogen

Pharm Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Onconase on double-stranded RNA in vitro.
Abha Saxena, Shailendra K Saxena, Kuslima Shogen

Anticancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cytotoxic ribonuclease onconase targets RNA interference (siRNA).
Hong Zhao, Barbara Ardelt, Wojciech Ardelt, Kuslima Shogen, Zbigniew Darzynkiewicz

Cell Cycle· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer.
Intae Lee, Kuslima Shogen

Cancer Chemother Pharmacol· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines.
Masamichi Ita, H Dorota Halicka, Toshiki Tanaka, Akira Kurose, Barbara Ardelt, Kuslima Shogen

Cancer Biol Ther· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Possible mechanisms of improved radiation response by cytotoxic RNase, Onconase, on A549 human lung cancer xenografts of nude mice.
Dae Hong Kim, Eun Ju Kim, Anna Kalota, Alan M Gewirtz, Jerry Glickson, Kuslima Shogen

Adv Exp Med Biol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The therapeutic mechanisms of ranpirnase-induced enhancement of radiation response on A549 human lung cancer.
Intae Lee, Dae H Kim, Ulas Sunar, Sergey Magnitsky, Kuslima Shogen

In Vivo· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytostatic and cytotoxic properties of Amphinase: a novel cytotoxic ribonuclease from Rana pipiens oocytes.
Barbara Ardelt, Wojciech Ardelt, Piotr Pozarowski, Jan Kunicki, Kuslima Shogen

Cell Cycle· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzymatic and structural characterisation of amphinase, a novel cytotoxic ribonuclease from Rana pipiens oocytes.
Umesh P Singh, Wojciech Ardelt, Shailendra K Saxena, Daniel E Holloway, Eugene Vidunas, Kuslima Shogen

J Mol Biol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The interdependence between catalytic activity, conformational stability, and cytotoxicity of onconase.
Cindy Schulenburg, Barbara Ardelt, Wojciech Ardelt, Ulrich Arnold, Kuslima Shogen

Cancer Biol Ther· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onconase induces caspase-independent cell death in chemoresistant neuroblastoma cells.
Martin Michaelis, Jaroslav Cinatl, Puja Anand, Florian Rothweiler, Rouslan Kotchetkov, Kuslima Shogen

Cancer Lett· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild hyperthermia predisposes tumor cells to undergo apoptosis upon treatment with onconase.
H Dorota Halicka, Barbara Ardelt, Kuslima Shogen, Zbigniew Darzynkiewicz

Int J Oncol· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antitumor efficacy of the cytotoxic RNase, ranpirnase, on A549 human lung cancer xenografts of nude mice.
Intae Lee, Anna Kalota, Alan M Gewirtz, Kuslima Shogen

Anticancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Jurkat acute T-lymphocytic leukemia cells by onconase (Ranpirnase) is accompanied by an altered nucleocytoplasmic distribution and reduced expression of transcription factor NF-kappaB.
Shwu Y Tsai, Barbara Ardelt, Tze-Chen Hsieh, Zbigniew Darzynkiewicz, Kuslima Shogen

Int J Oncol· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ONCONASE +/- tamoxifen on ASPC-1 human pancreatic tumors in nude mice.
Intae Lee, Young H Lee, Stanislaw M Mikulski, Kuslima Shogen

Adv Exp Med Biol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Entry into cells and selective degradation of tRNAs by a cytotoxic member of the RNase A family.
Shailendra K Saxena, Ravi Sirdeshmukh, Wojciech Ardelt, Stanislaw M Mikulski, Kuslima Shogen

J Biol Chem· April 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma.
Stanislaw M Mikulski, John J Costanzi, Nicholas J Vogelzang, Spence McCachren, Robert N Taub, Kuslima Shogen

J Clin Oncol· January 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis